Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(42.9%)

Early Phase 1

1(14.3%)

Phase 1

1(14.3%)

Phase 3

1(14.3%)

Phase 2

1(14.3%)

7Total

N/A(3)

Early Phase 1(1)

Phase 1(1)

Phase 3(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07495046Not ApplicableNot Yet Recruiting

Low Excision and High Suspension Hemorrhoidectomy Versus Conventional Milligan-Morgan Hemorrhoidectomy for Grade III-IV Mixed Hemorrhoids

Role: lead

NCT07128953Early Phase 1Enrolling By Invitation

Study on the Mechanism of Zuoqing San Promoting Postoperative Wound Healing of Anal Fistula by Inhibiting ROS-dependent NETosis

Role: lead

NCT06663527Not ApplicableCompleted

Compound Phellodendron Decoction May Promote Wound Healing After Anal Fistulotomy

Role: lead

NCT06680882Phase 2Not Yet Recruiting

The Effect of Non-invasive Auricular Acupoint Stimulation on Slow Transmission Constipation

Role: lead

NCT06667934Phase 1Not Yet Recruiting

Clinical Trial of Zuoqing SAN in Treating Ulcerative Colitis

Role: lead

NCT06660680Phase 3Enrolling By Invitation

The Effect of Methylene Blue Infiltrating Injection on Anal Pain After Milligan-Morgan Surgery: a Randomized Controlled Clinical Study

Role: lead

NCT02587585Not ApplicableUnknown

The Effect of Activity Feedback Enabled by Smart Watches During In-patient Stroke Rehabilitation

Role: lead

All 7 trials loaded